• Molecular structure of a tau inhibitor
    Science News
    Using atomic-level imaging, Paul Seidler, UCLA, looks at how tau protein creates tangles in Alzheimer’s—and how to stop it with well-designed drugs. The work is supported by a partnership between BrightFocus and Alzheimer’s Greater Los Angeles. .
    Wednesday, December 13, 2017
  • Recently more than 100 vision scientists attended the first-ever BrightFocus Glaucoma Fast Track.  By jump-starting research careers and fostering collaboration, the workshop will speed progress towards new treatments and cures.
    Science News
    BrightFocus Foundation recently held its first-ever Glaucoma FastTrack to accelerate the fight for a cure by investing in promising young scientists in the field of vision research.
    Thursday, November 30, 2017
  • Science News
    A groundbreaking study is providing a more complete understanding of how Alzheimer’s disease worsens in the brain, helping to unite what had been two separate schools of thought on the causes of Alzheimer’s, and accelerating future research into effective treatments and cure.
    Thursday, November 2, 2017
  • Dr. Lewin, right, and Manas Biswal, PhD, co-PI, in their U. of Fla. lab.
    Science News
    Two scientists at the University of Florida, supported by a grant from BrightFocus’ Macular Degeneration Research program, have uncovered some tantalizing clues that a drug previously investigated to protect against nerve damage during cancer treatment could offer some protection for the nerve cells of the eye in late-stage dry age-related macular degeneration.
    Tuesday, October 17, 2017
  • Science News
    Kip Connor, PhD, with funding from Macular Degeneration Research (MDR), has lead a team of experts to discover an important role of immune cells that regulate, and could potentially stop, abnormal blood vessel growth in advanced age-related macular degeneration (AMD).
    Tuesday, September 5, 2017
  • Don't miss out.
    Receive research updates, inspiring stories, and expert advice
    Keep me imformed about: *
    Please select at least one.
    You must select at least one disease category.
    Please enter your first name.
    Please enter your last name.